In Vitro Antibacterial Activity of Cefiderocol against Multidrug-Resistant Acinetobacter baumannii
Published 2021 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
In Vitro
Antibacterial Activity of Cefiderocol against Multidrug-Resistant Acinetobacter baumannii
Authors
Keywords
-
Journal
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
Volume 65, Issue 9, Pages -
Publisher
American Society for Microbiology
Online
2021-06-15
DOI
10.1128/aac.02646-20
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Structural basis of reduced susceptibility to ceftazidime–avibactam and cefiderocol in Enterobacter cloacae due to AmpC R2 loop deletion
- (2020) Akito Kawai et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Cefiderocol: A Siderophore Cephalosporin with Activity Against Carbapenem-Resistant and Multidrug-Resistant Gram-Negative Bacilli
- (2019) George G. Zhanel et al. DRUGS
- Therapeutic drug monitoring-based dose optimisation of piperacillin/tazobactam to improve outcome in patients with sepsis (TARGET): a prospective, multi-centre, randomised controlled trial
- (2019) Stefan Hagel et al. Trials
- Carbapenem Non-susceptible Gram-negative Pathogens in ICU and Non-ICU Settings in US Hospitals in 2017: A Multicenter Study
- (2018) Eilish McCann et al. Open Forum Infectious Diseases
- Active efflux pump adeB is involved in multidrug resistance of Acinetobacter baumannii induced by antibacterial agents
- (2017) Tingting Zhang et al. Experimental and Therapeutic Medicine
- Siderophore Cephalosporin Cefiderocol Utilizes Ferric Iron Transporter Systems for Antibacterial Activity againstPseudomonas aeruginosa
- (2016) Akinobu Ito et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Activity of Ceftazidime-Avibactam against Extended-Spectrum- and AmpC β-Lactamase-Producing Enterobacteriaceae Collected in the INFORM Global Surveillance Study from 2012 to 2014
- (2016) James A. Karlowsky et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Colistin-Resistant Acinetobacter baumannii: Beyond Carbapenem Resistance
- (2015) Zubair A. Qureshi et al. CLINICAL INFECTIOUS DISEASES
- In vitro synergy of polymyxins with other antibiotics for Acinetobacter baumannii: A systematic review and meta-analysis
- (2015) Wentao Ni et al. INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS
- Meta-analysis of colistin for the treatment of Acinetobacter baumannii infection
- (2015) Zhijin Chen et al. Scientific Reports
- Ceftazidime-Avibactam: a Novel Cephalosporin/β-lactamase Inhibitor Combination
- (2013) George G. Zhanel et al. DRUGS
- Carbapenem-resistantAcinetobacter baumannii: epidemiology, surveillance and management
- (2013) Jason M Pogue et al. Expert Review of Anti-Infective Therapy
- Multidrug resistance among Acinetobacter spp. in the USA and activity profile of key agents: results from CAPITAL Surveillance 2010
- (2012) Anne Marie Queenan et al. DIAGNOSTIC MICROBIOLOGY AND INFECTIOUS DISEASE
- Extended-Spectrum AmpC Cephalosporinase in Acinetobacter baumannii: ADC-56 Confers Resistance to Cefepime
- (2011) Guo-Bao Tian et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Multiresistant Acinetobacter baumannii infections: epidemiology and management
- (2010) José Garnacho-Montero et al. CURRENT OPINION IN INFECTIOUS DISEASES
- In vitro synergistic activity of tigecycline and colistin against XDR-Acinetobacter baumannii
- (2009) Murat Dizbay et al. JOURNAL OF ANTIBIOTICS
Add your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload NowBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started